Latest News

The decision followed a comprehensive systematic review of published literature, which included case reports containing patient-level data and mechanistic studies that demonstrated the treatment’s potential benefits.

The expansion of Cosentyx to this population addresses a critical gap in care and demonstrates Novartis’ focus on advancing solutions where the company can make the greatest impact on patient outcomes.

The FDA based its approval decision on data from a global Phase IIIb clinical trial demonstrating Arexvy’s effectiveness in the younger adult population.

The platform serves multiple surgical disciplines, including arthroscopy, bariatric surgery, general surgery, gynecology, hepatopancreatobiliary transplant procedures, thoracic surgery, and urology.

The recognition provides an important reference point for other countries working to strengthen their regulatory systems.

The technology delivers highly precise radiation treatment with sub-millimeter accuracy, enabling doctors to target tumors more effectively while minimizing damage to surrounding healthy tissue.

LYOCONTRACT has partnered with Syntegon, a leading equipment supplier, to install a complete filling and lyophilization line at the new facility.

The publication emphasizes physician training and professional development, with particular attention to digital innovation.

Alzheimer’s disease drives up to 70% of dementia cases worldwide, presenting healthcare systems with mounting challenges.

Researchers plan to enroll approximately 190 women aged 18 to 45 across seven European countries, including the UK, Italy, Poland, Romania, Bulgaria, the Czech Republic, and Hungary.